CU Anschutz In The News

The pilot program, administered by the College of Nursing at the University of Colorado Anschutz, had two goals. The first was to increase access to MAT services and medications which include methadone, buprenorphine and naltrexone. "Those are either medications that help you to not go into withdrawal and help to rebalance the chemical imbalance in your brain that may happen when you have an opioid use disorder," said Tanya Sorrell, an associate professor at the College of Nursing, who helped oversee the grants.

If physicians are going to continue to shape the future of health care they will need to “win the fourth industrial revolution,” according to Arlen Meyers, MD, an otolaryngologist who also has a master’s degree in business.
Dr. Meyers—a professor emeritus at the University of Colorado School of Medicine and president and CEO of the Society of Physician Entrepreneurs—defines the fourth industrial revolution as one that is shaped by the opportunities and challenges associated with emerging physical, digital and biologic technologies.

“We want to study what our patients are using,” said University of Colorado Assistant Professor Emily Lindley, who is investigating marijuana with high THC as an alternative to opioids for chronic back pain.
Lindley and other researchers want others besides the University of Mississippi to get federal authorization to grow research pot.

"They do get out," said Robert Valuck, a University of Colorado pharmaceutical professor. "It could be someone in the office took one, it could be a patient that sees a pad laying around and takes the prescription pad."

But for medical students such as Aly Sotiros, the stringent abortion laws passed by some states are already playing a role in where they might go for training — or, eventually, to practice medicine. “We traveled to Alabama for vacation a few months ago, and as much as we loved the beach, we said we can’t ever move here because I would be put in jail,” said Sotiros, a student at the CU School of Medicine.

"It's a question of how we want to manage the risk,” said Jon Samet, who chaired the WHO's working group on its International Agency for Research on Cancer, and is now the dean of the University of Colorado’s School of Public Health. “Are we going to be precautionary — which would be, you stop the technology or you minimize human contact with it — or not?”

A few years ago, microbiologist Catherine Louzopone and colleagues at the University of Colorado School of Medicine were studying metabolism-related health problems in men and women infected with HIV. Previous research had suggested that T cells with higher metabolic activity might be more susceptible to viral infection.

“This is really a completely different approach than anything that has been tried before,” said Huntington Potter, director of the Rocky Mountain center, which is part of the University of Colorado. “It is one approach of many, and we’re hopeful. But science will tell.”